Dianthus Therapeutics Inc (DNTH)
EBITDA Growth
-58.92%
Quarterly · Period ending:
DNTH EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-58.92%period ending
Latest reported-58.92%period ending
DNTH Quarterly EBITDA YoY % (-130.51% → -58.92%)
Year-over-year change
High-resolution chart · PNG
DNTH ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -58.9217% | |
| -38.7365% | |
| 445.5398% | |
| -46.3245% | |
| -80.2126% | |
| -115.3654% | |
| -171.1472% | |
| -69.9539% | |
| -34.8543% | |
| -94.649% | |
| -3.9038% | |
| -124.3116% | |
| 19.2908% | |
| 67.7645% | |
| 46.3294% | |
| 61.095% | |
| 2.2737% | |
| -27.7696% | |
| -6.1337% | |
| 1.6761% | |
| 11.4884% | |
| 12.8241% | |
| 22.3233% | |
| 16.2091% | |
| -7.6959% | |
| -35.4382% | |
| -39.4118% | |
| -29.7419% | |
| -27.8222% | |
| -30.8426% | |
| -106.3994% | |
| -132.6122% | |
| 13.6553% | |
| -130.5149% |